FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Lorazepam Injection
Status: Currently in Shortage
»Date first posted: 05/03/2018
»Therapeutic Categories: Neurology

Amphastar Pharmaceuticals, Inc. (Reverified 04/09/2025)

Company Contact Information:
800-423-4136

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1)	Available

Hikma Pharmaceuticals USA, Inc. (Revised 04/11/2025)

Company Contact Information:
800-631-2174

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25)	Unavailable	Additional lots are scheduled to be manufactured. Product will be made available as it is released.	Demand increase for the drug
Ativan, Injection, 2 mg/1 mL (NDC 0641-6000-10)	Unavailable	Additional lots are scheduled to be manufactured. Product will be made available as it is released.	Demand increase for the drug
Ativan, Injection, 4 mg/1 mL (NDC 0641-6003-25)	Unavailable	Additional lots are scheduled to be manufactured. Product will be made available as it is released.	Demand increase for the drug
Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10)	Unavailable	Additional lots are scheduled to be manufactured. Product will be made available as it is released.	Demand increase for the drug
Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25)	Unavailable	Additional lots are scheduled to be manufactured. Product will be made available as it is released.	Demand increase for the drug
Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10)	Unavailable	Additional lots are scheduled to be manufactured. Product will be made available as it is released.	Demand increase for the drug
Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6045-25)	Unavailable	Additional lots are scheduled to be manufactured. Product will be made available as it is released.	Demand increase for the drug
Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6047-10)	Unavailable	Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.	Demand increase for the drug

Hospira, Inc., a Pfizer Company (Revised 04/11/2025)

Company Contact Information:
844-646-4398

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30)	Unavailable	Next Delivery: May 2025; Estimated Recovery: September 2025	Other